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Abstract
Background: It has been reported that 15-20% of parous female have experienced at 
least one miscarriage, while 3% of them have experienced two miscarriages. The goal of 
this study was to evaluate the plasma level of coagulation factors  in women with a his-
tory of spontaneous abortions.   
Materials and Methods: In this case-control study, 82 women with a history of two 
or more abortions referred to the six private gynecologic clinics in Gorgan city without 
any structural abnormality were recruited during 2011-2012. Plasma levels of antithrom-
bin III (ATIII) using colorimetric assay, protein C, protein S, factor V Leiden and lupus 
anticoagulant (LAC) using coagulation method were measured. The control group was 
women with a history of normal delivery and no abortions. Those under anti-coagulant 
therapy were excluded from the study. Data were entered into the computer using the 
Statistical Package for the Social Sciences (SPSS, SPSS Inc., Chicago, IL, USA) version 
16 and analyzed by Chi-square, t test and non-parametric tests.   
Results: At least one abnormality was reported in 35 cases (42.7%). Among them, pro-
tein C deficiency was the most prevalent (30.5%). ATIII was abnormal in 17.1% and 
lupus anti-coagulant was abnormal in 8.5%. Factor V Leiden was normal in all cases 
and protein S deficiency was only seen in one case. 
Conclusion: We suggest to perform these tests in regards to the thrombophilia in cases 
with spontaneous abortions in order to find an early cure for this treatable disorder.     
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Introduction 
It has been reported that 15-20% of all parous 
women have experienced at least one miscarriage, 
3% have experienced two miscarriages and finally 
1% have experienced three or more miscarriages 
(1). Recurrent pregnancy loss (RPL) is defined as 
two or more consecutive pregnancy losses before 
the 28th week of pregnancy with fetus weighing 
less than 1000 g. RPL affects 2-4% of  reproduc-
tive  age couples worldwide (2, 3).  Several differ-
ent etiologies have been defined for RPL such as: 
genetic factors, structural abnormalities, endocrine 
disorders like thyroid hormone alteration, immu-
nologic factors, infective causes and unexplained 
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causes (3).
There are still debates on the role of immuno-
logic factors as the pathogenesis of recurrent mis-
carriages (1, 4). Several risk factors as definitive 
or probable causes of RPL have been reported 
for women with recurrent pregnancy loss, like 
acquired maternal thrombophilia and inherited 
thrombophilia that include factor V Leiden defi-
ciency, activated protein C resistance, prothrombin 
G20210A and protein S deficiency (4, 5).
There are few data about the spontaneous preg-
nancy loss in Iranian women in regards to throm-
bophilia markers. Therefore, we conducted this 
study to evaluate the plasma level of thrombophil-
ia markers in women with a history of two or more 
abortions.
Materials and Methods
In this case-control study, 100 women with preg-
nancy loss history were referred to the academic 
and  six private gynecologic clinics in Gorgan city, 
during 2011-2012. The inclusion criteria were a 
history of at least two pregnancy losses and no 
structural abnormality in the genital tract. Those 
undergoing anti-coagulant therapy were excluded 
from the study. Considering the inclusion crite-
ria, 82 women were enrolled in our study. This 
study was confirmed by the Ethics Committee of 
Golestan University of Medical Sciences, Gorgan, 
Golestan Province, Iran. After obtaining informed 
consent from participants, the checklist was filled 
and they were referred to the Immunohematology 
Laboratory of Paramedicine Faculty of Golestan 
University of Medical Sciences.  Control group in-
cluded 86 age-matched women who experienced a 
normal pregnancy history for less than a year.
Plasma levels of anti-thrombin III (ATIII) was 
evaluated using colorimetric assay ( Stago Kit, Di-
agnostica Stago, Inc., France). Protein C, protein 
S, factor V Leiden and lupus anticoagulant (LAC) 
were also evaluated using coagulation methods 
(Hyphen Biomed Kit, Amelung coagulometer In-
strument, France). All laboratory tests were done 
in a single center. 
The lower limit of the reference interval values 
for protein C, protein S, ATIII and factor V Leiden 
are 70, 55, 80 and 1.8%,  respectively. Reference 
interval value for LAC  was normal, less than 40 
seconds.   
Data were entered into the computer using the 
Statistical Package for the Social Sciences (SPSS, 
SPSS Inc., Chicago, IL, USA) version 16. Mean 
values of factors were reported. P value<0.05 was 
considered significant. 
Results
Mean (±SD) age was 28.97 (±5.19) years in case 
group and 29.18 (±5.93) years in control group. 
The median pregnancy loss in cases was 2 (±0.85), 
minimum 2 and maximum 7 abortions.  In the con-
trol group,  the minimum values belonging to pro-
tein C, protein S, ATIII and factor V Leiden were 
70.1, 60, 80, and 1.9%, respectively, while maxi-
mum value for LAC was normal less than 39.8 
seconds.   
Factor V Leiden was normal (>1.8) in all cases. 
LAC was abnormal (≥40) in 7 (8.5%), ATIII (<80) 
in 14 (17.1%), protein S (<55%) in 1 and protein C 
(<70%) in 25 (30.5%) (Table 1).
In about 35 cases (42.7%), at least one abnor-
mality was reported in the lab tests. No one had 
all abnormalities at once, but there was a case with 
triple abnormalities in protein C, ATIII and LAC. 
One case had both abnormalities in protein C and 
protein S. In 3 cases, there was an abnormality in 
both protein C and LAC, and in 8 cases, protein C 
and ATIII were abnormal at once.
Table 1: Comparison of mean values of five thrombophilia 
factors between case and control groups 
P valueControl Case Factors
0.32332.0 ± 6.534.1 ± 14.7LAC (s)
0.152123.1 ± 52.3111.4 ± 52.1ATIII (%)
0.2313.0 ± 0.82.8 ± 0.7Factor V Leiden 
(Ratio)
<0.001119.6 ± 35.790.4 ± 38.6Protein C (%)
0.353102.0 ± 20.2105.2 ± 23.7Protein S (%)
All data were presented as mean ± standard deviation (SD). LAC; 
Lupus anticoagulant and ATIII; Anti-thrombin III.
Discussion
Abnormality in protein C has been reported in a 
relatively high percent of the cases with a history 
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of abortion in the present study. Abnormal Factor 
V Leiden and protein S were not seen almost at all, 
but in other studies, they were reported to have a 
high prevalence.
D’Uva et al. (6) from Italy reported thrombo-
philia in 78% of cases with history of recurrent 
abortion and 16% of controls. They reported that 
abnormal ATIII was not seen in their population. 
Furthermore their findings showed that Factor V 
Leiden heterozygosity was present in 5.2%, pro-
tein C deficiency in 1.7% and protein S deficiency 
in 13%, indicating that protein C and protein S lev-
els are lower and higher, respectively, than what 
we found in our study group.
Bellver et al. (5) from Spain designed a study on 
4 groups including control group, without a history 
of abortion; unexplained infertility (UI) group, a 
history of fertility more than one year without any 
autoimmune endocrine diseases; in vitro fertiliza-
tion (IVF) group; normal Caucasian women group 
aged under 38 years and with unsuccessful IVF; 
and recurrent abortion group. Combined thrombo-
philia (abnormality in all five factors) was seen in 
3 (9.4%) of controls, 3 of UI groups (9.7%), 5 in 
IVF group (19.2%) and 2 of recurrent abortions 
(6.7%) . However, in the present, there was no case 
of combined abnormality.
Mitic et al. (7) reported at least one congenital 
thrombophilia alteration in 54 (36.7%) women 
with a history of abortion, while protein S defi-
ciency was the most prevalent one among them. 
Our results showed that protein S deficiency is 
present in just one case and protein C deficiency is 
the most prevalent one. Our finding indicated that 
alteration in at least one factor was reported in 35 
cases (42.7%).
Jyotsna et al. (8) from India reported a sig-
nificantly lower protein C, protein S and ATIII 
in cases with a history of abortion. The level of 
protein C was lower than normal in 33.3% of 
their cases. Their findings showed that levels 
of protein C, protein S and ATIII were lower 
as compared to related values of our findings, 
while the percentage of abnormal tests are more 
than the present study. In a study by Saadati et 
al. (9) in  Iran, 3 cases (8.4%) and no control 
had LAC positive results.
In a study performed in Pakistan, opposite re-
sults have been reported. Their study included 52 
women with a history of recurrent miscarriage and 
268 healthy controls. The values of protein factors 
C (5.7 in patients vs. 6.7% in the control group), 
protein S (3.8 in patients vs. 4.5% in the control 
group) and Leiden factor (19.2 in patients vs. 
10.0% in the control group) were significantly dif-
ferent between patient and control groups. How-
ever, antithrombin deficiency in the control group 
was significantly greater than the patient group 
(1.9 in patients  vs. 15.2 % in the control group) 
(10), suggesting that there may be a problem in 
their selection of subjects recruited into the control 
group. 
Conclusion
We suggested to perform these tests, specially 
protein C, in regards to the thrombophilia in cases 
with spontaneous abortions in order to find an ear-
ly cure for this treatable disorder.
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